EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Endodontic Treatment of Apical Periodontitis Mitigates Systemic Inflammation and Restores the Blood–Brain Barrier Integrity in an In Vitro Model

Loredana Bergandi iD, Mario Alovisi iD, Elena Tachis, Nicola Scotti iD, Andrea Baldi iD, Iris Chiara Salaroglio iD, Sabrina Digiovanni iD, Lorena Charrier iD, Francesca Silvagno iD, Damiano Pasqualini iD

International Endodontic Journal · 2026

DOI: 10.1111/iej.70216 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Endodontic Journal, 2026. Verfasst von Loredana Bergandi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, University of Turin, Turin, Piedmont, Italy. Hauptthemen laut MEDLINE: Periapical Periodontitis, Blood-Brain Barrier, Root Canal Therapy, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Istruzione, dell'Università e della Ricerca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

A growing body of research supports an association between periapical inflammation and an increased risk of various systemic effects. However, there is currently no scientific evidence demonstrating a causal relationship between this inflammation and changes in epithelial or endothelial permeability in patients with apical periodontitis (AP). This study aimed to evaluate the potential association between AP, circulating inflammatory cytokines known to affect cellular permeability, and serum proteins associated with an impaired cellular barrier permeability. Additionally, we investigated the effect of endodontic treatment on in vitro endothelial barrier integrity. Methodology A total of 27 patients with AP and 27 healthy control subjects were enrolled. AP patients underwent root canal treatment and were followed up at 6 and 12 months post‐treatment. Serum levels of human ZO‐1, Claudin‐5, and VE‐cadherin were measured using enzyme‐linked immunosorbent assays (ELISA). An in vitro model of the microvascular endothelial blood–brain barrier (hCMEC/D3 cells) was used to assess the biological activity of patient sera on barrier function and cellular permeability.

Results

At baseline, patients with AP showed significantly higher serum levels of ZO‐1 and Claudin‐5 compared with controls ( p < 0.001), whereas VE‐cadherin levels did not differ significantly between groups. Serum ZO‐1 and Claudin‐5 levels progressively decreased at 6 and 12 months following root canal treatment. In adjusted analyses, the baseline between‐group differences for ZO‐1 and Claudin‐5 remained significant after adjustment for BMI and smoking status. ZO‐1 and Claudin‐5 levels showed moderate correlations with IL‐1β and IL‐6 in the AP group at baseline. In vitro, exposure to baseline AP sera increased endothelial permeability, indicating barrier disruption, while sera collected after treatment did not impair barrier integrity. Moreover, cellular ZO‐1 expression remained stable in cells treated with control sera but was markedly reduced after exposure to sera from untreated AP patients (t0), whereas post‐treatment sera (t6 and t12) restored ZO‐1 expression to control levels.

Conclusions

Systemic inflammation in patients with apical periodontitis to deranged endothelial barrier function. Successful endodontic treatment was associated with reduced levels of inflammatory cytokines and the restoration of serum and cellular proteins essential for barrier integrity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Periapical PeriodontitisBlood-Brain BarrierRoot Canal TherapyInflammationHumansFemaleAdultMaleZonula Occludens-1 ProteinEnzyme-Linked Immunosorbent AssayAntigens, CDClaudin-5CadherinsMiddle AgedIn Vitro TechniquesCadherin 5Cytokines

Stichwörter der Autor:innen

apical periodontitisbarrier integritycellular permeabilityinflammation

Substanzen

Zonula Occludens-1 ProteinAntigens, CDClaudin-5CadherinsTJP1 protein, humanCadherin 5Cytokines

Autor:innen und Institutionen

  • Department of Oncology, University of Turin, Turin, Piedmont, Italy.
  • Department of Surgical Sciences, Dental School, Endodontics Unit, University of Turin, Turin, Piedmont, Italy.
  • Molecular Biotechnology Centre Guido Tarone, University of Turin, Turin, Piedmont, Italy.
  • Department of Public Health and Pediatrics, University of Turin, Turin, Piedmont, Italy.

ORCID-Profile: Loredana Bergandi, Mario Alovisi, Nicola Scotti, Andrea Baldi, Iris Chiara Salaroglio, Sabrina Digiovanni, Lorena Charrier, Francesca Silvagno, Damiano Pasqualini

Förderung

  • Ministero dell'Istruzione, dell'Università e della Ricerca

Zitieren

APA

Bergandi, L., Alovisi, M., Tachis, E., Scotti, N., Baldi, A., Salaroglio, I. C., Digiovanni, S., Charrier, L., Silvagno, F., & Pasqualini, D. (2026). Endodontic Treatment of Apical Periodontitis Mitigates Systemic Inflammation and Restores the Blood–Brain Barrier Integrity in an In Vitro Model. International Endodontic Journal. https://doi.org/10.1111/iej.70216

Vancouver

Bergandi L, Alovisi M, Tachis E, Scotti N, Baldi A, Salaroglio IC, et al. Endodontic Treatment of Apical Periodontitis Mitigates Systemic Inflammation and Restores the Blood–Brain Barrier Integrity in an In Vitro Model. International Endodontic Journal. 2026. doi:10.1111/iej.70216

BibTeX
@article{Bergandi2026,
  author = {Bergandi, Loredana and Alovisi, Mario and Tachis, Elena and Scotti, Nicola and Baldi, Andrea and Salaroglio, Iris Chiara and Digiovanni, Sabrina and Charrier, Lorena and Silvagno, Francesca and Pasqualini, Damiano},
  title = {Endodontic Treatment of Apical Periodontitis Mitigates Systemic Inflammation and Restores the Blood–Brain Barrier Integrity in an In Vitro Model},
  journal = {International Endodontic Journal},
  year = {2026},
  doi = {10.1111/iej.70216}
}
Kostenlos starten →